Cargando…
Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?
Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effectiv...
Autores principales: | Sobota-Grzeszyk, Angelika, Kuźmicki, Mariusz, Szamatowicz, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925787/ https://www.ncbi.nlm.nih.gov/pubmed/31886278 http://dx.doi.org/10.1155/2019/3915253 |
Ejemplares similares
-
miRNAs as Predictive Factors in Early Diagnosis of Gestational Diabetes Mellitus
por: Juchnicka, Ilona, et al.
Publicado: (2022) -
Increased Maternal and Cord Blood Betatrophin in Gestational Diabetes
por: Wawrusiewicz-Kurylonek, Natalia, et al.
Publicado: (2015) -
Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes
por: Juchnicka, Ilona, et al.
Publicado: (2022) -
Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systematic review and meta-analysis
por: Bertrand, Anthéa, et al.
Publicado: (2022) -
Effectiveness and acceptability of myoinositol in prevention of gestational diabetes mellitus: A protocol for systematic review and meta-analysis
por: Wang, Li, et al.
Publicado: (2021)